Reproductive Health Matters
Volume 15, Issue 29, Supplement , Pages 67-92 , May 2007

Sexual Health for People Living with HIV

  • Kathy Shapiro

      Affiliations

    • Independent consultant, New Delhi, India
    • ,
  • Sunanda Ray

      Affiliations

    • Public health physician, Brighton and Hove Teaching Primary Care Trust, Brighton, UK

References 

  1. Report of a Technical Consultation on Sexual Health. 28-31 January 2002. Geneva: WHO; 2006;At: < www.who.int/reproductive-health/gender/sexual_health.html#3>. Accessed 17 March 2007
  2. International Community of Women Living With HIV/AIDSGender Aids ForumICW Durban. Confronting marginalization together in the context of HIV/AIDS. At: < www.icw.org/node/46>. Accessed 7 December 2006
  3. International HIV/AIDS Alliance. Positive Prevention: prevention strategies for people with HIV/AIDS. Emerging Practice Series. Draft background paper, July 2003. At: < www.aidsalliance.org/sw9438.asp>
  4. Bunnell R, Mermin J, De Cock KM. HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA. 2006;296(7):855–858
  5. Global consultation on the rights of people with HIV to sexual and reproductive health, Addis Ababa, 27–30 March 2006. At: < www2.who.int/reproductive-health/hiv/final_global_consultation.pdf>. Accessed 15 March 2007
  6. Positive Outcomes. Finding HIV positive youth and bringing them into care. Washington DC: AIDS Alliance for Children, Youth and Families; 2005;At: < http://aids-alliance.intrasmart.com/isdoclibrary/files/951839/957442/20053261598389/Finding%20HIV-Positive%20Youth.pdf>
  7. Garvey M. Dying to learn: young people HIV and the churches. Christian Aid, October 2003. At: < www.christian-aid.org.uk/indepth/310learn/dyingtolearn.pdf>
  8. Ybarra ML, Kiwanuka J, Emenyonu N, et al. Internet use among Ugandan adolescents: implications for HIV intervention [abstract]. PloS Medicine. 2006;3(11):e433
  9. International Community of Women Living With HIV/AIDS. HIV Positive Women in Thailand: Their Voices and Choices. A Study Conducted by and for HIV Positive Women. At: < www.icw.org/files/Voices_and_Choices_Thailand.pdf>. Accessed 30 November 2005
  10. Kirby D. Emerging answers: research findings on programmes to reduce teen pregnancy. Washington DC: National Campaign to Prevent Teen Pregnancy, 2001. p. 5, 88–91.
  11. Manlove J, Romano Papillio A, Ikramullah E. Not yet: programmes to delay first sex among teens. Washington DC: National Campaign to Prevent Teen Pregnancy; 2004;
  12. Gallant M, Maticka-Tyndale E. School-based HIV prevention programmes for African youth. Review. Social Science and Medicine. 2004;58(7):1337–1351
  13. Magnani R, Macintyre K, Karim AM, et al. The impact of life skills education on adolescent sexual risk behaviours in KwaZulu-Natal, South Africa. Journal of Adolescent Health. 2005;36(4):289–304
  14. US Government Accountability Office. Report to Congressional Committees. Global Health: Spending Requirement Presents Challenges for Allocating Prevention Funding under the President's Emergency Plan for AIDS Relief. GAO-06-395. Washington DC: US GAO; April 2006;
  15. Gordon G, Mwale V. Preventing HIV with young people: a case study from Zambia. Reproductive Health Matters. 2006;14(28):68–79
  16. Bearman P, Bruckner H. After the promise: the STD consequences of adolescent virginity pledges, 2004. At: < www.yale.edu/socdept/CIQLE/cira.ppt>
  17. Eyes Wide Shut – sexuality and risk in HIV-positive youth in Sweden: a qualitative study. Scandanavian Journal of Public Health. 2007;35(1):55–61
  18. United Nations. General Comment No.3 (2003). HIV/AIDS and the rights of the child. Thirty-second session 13–31 January 2003. CRC/GC/2003/3. 17 March 2003. Quoted in Bosmans et al.
  19. Médécins sans Frontières South Africa Internal newsletter. February–June 2005. At: < www.doctorswithoutborders.org/news/southafrica.cfm>
  20. UN Development Programme. Training HIV/AIDS positive youth to enhance their potential for employment. (no date). At: < www.undp.org.za/projects/training_hiv.html>
  21. Augustine J. Serving HIV-positive youth. Washington DC: Advocates for Youth; November 2002;At: < www.advocatesforyouth.org/PUBLICATIONS/iag/hivpositive.pdf>
  22. Frieden TR, Das-Douglas M, Kellerman SE, Henning KJ. Applying public health principles to the HIV epidemic. New England Journal Medicine. 2005;353(22):2397–2402
  23. Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet. 2000;356(9224):103–112
  24. Weinhardt LS, Carey MP, Johnson BT, et al. Effects of HIV counselling and testing on sexual risk behaviour: a meta-analytic review of published research 1985–1997. American Journal of Public Health. 1999;89:1397–1405
  25. Weinhardt LS, Kelly JA, Brondino MJ, et al. HIV transmission risk behaviour among men and women living with HIV in four cities in the United States. Journal of Acquired Immune Deficiency Syndrome. 2004;36:1057–1066
  26. Johnson BT, Carey MP, Chaudoir SR, et al. Sexual risk reduction for persons living with HIV; research synthesis of randomized controlled trials, 1993–2004. Journal of Acquired Immune Deficiency Syndrome. 2006;41:642–649
  27. Roth DL, Stewart KE, Clay OJ, et al. Sexual practices of HIV discordant and concordant couples in Rwanda: effects of a testing and counselling programme for men. International Journal STD & AIDS. 2001;12(3):181–188
  28. Allen S, Meinzen-Derr J, Kautzman M, et al. Sexual behaviour of HIV discordant couples after HIV counselling and testing. AIDS. 2003;17:733–740
  29. Santos N, Ventura-Filipe E, Paiva V. HIV positive women, reproduction and sexuality in São Paulo, Brazil. Reproductive Health Matters. 1998;6(12):31–40
  30. UNAIDS. Intensifying HIV Prevention. UNAIDS Policy Position Paper. Geneva: UNAIDS; August 2005;
  31. Castro A, Farmer P. Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. American Journal of Public Health. 2005;95:53–59
  32. Levy NC, Miksad RA, Fein OT. From treatment to prevention: the interplay between HIV/AIDS treatment availability and HIV/AIDS prevention programming in Khayelitsha, South Africa. Journal of Urban Health. 2005;82(3):498–509
  33. Feldman R, Manchester J, Maposhere C. Positive Women: Voices and Choices: A Zimbabwe Report. Harare: SAfAIDS; 2002;
  34. Bouhnik AD, Preau M, Schilts MA and the VESPA Study Group. Unprotected sex in regular partnerships among homosexual men living with HIV: a comparison between sero-nonconcordant and seroconcordant couples (ANRS-EN12-VESPA Study). AIDS. 2007;21(Suppl.1):S43–S48
  35. UNAIDS/WHO. Opening Up the HIV/AIDS Epidemic. Guidance on encouraging beneficial disclosure, ethical partner counselling and appropriate use of HIV case-reporting. UNAIDS Best Practice Collection. Geneva: UNAIDS/WHO; November 2000;
  36. General Medical Council UK. Serious Communicable Diseases 1997. At: < www.gmc-uk.org/guidance>
  37. European Collaborative Study. The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West. AIDS. 2006;20:1419–1427
  38. UNAIDS, WHO. AIDS Epidemic Update. Geneva: UNAIDS; December 2005;
  39. Ray S, Latif A, Machekano R, et al. Sexual behaviour and risk assessment of HIV seroconvertors among urban male factory workers in Zimbabwe. Social Science and Medicine. 1998;47(10):1431–1443
  40. Bernard EJ. BHIVA: Recent gay seroconverters explain why they became HIV-infected. Aidsmap News. 6 April 2006. At: < www.aidsmap.com>
  41. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. New England Journal of Medicine. 2000;342(13):921–929
  42. Jones RB, Wasserheit JN. Introduction to the biology and natural history of sexually transmitted diseases. In:  Wasserheit JN, et al. editor. Research Issues in Human Behaviour and Sexually Transmitted Diseases in the AIDS Era. Washington DC: American Society for Microbiology; 1991;
  43. Berger J. Resexualizing the epidemic: desire, risk and HIV prevention. Development Update. 2004;5(3):At: < www.sarpn.org.za/documents/d0001195/2-Resexualising the Epidemic-Jonathan_Berger.pdf>
  44. Kippax S, Slavin S, Ellard J, et al. Seroconversion in context. AIDS Care. 2003;15(6):839–852
  45. Ray S, van de Wijgert J, Mason P, et al. Constraints faced by sex workers in use of female and male condoms for safer sex in urban Zimbabwe. Journal of Urban Health: Bulletin of the New York Academy of Medicine. 2002;78(4):581–592
  46. Estcourt CS, Marks C, Rohrsheim R, et al. HIV, sexually transmitted infections, and risk behaviours in male commercial sex workers in Sydney. Sexually Transmitted Infections. 2000;76(4):294–298
  47. Jolly S. Vulnerability, risk and sexual rights. Think piece for ‘AIDS and Vulnerability’ brainstorming workshop. UNAIDS/IDS, 23–24 June 2005. At: < www.eldis.org/cf/rdr/rdr.cfm?doc=DOC20>
  48. Castilla J, del Romero J, Hernando V, et al. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. Journal of Acquired Immune Deficiency Syndrome. 2005;40:96–101
  49. Gray RH, Li X, Wawer MJ, et al. Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission, Rakai, Uganda. AIDS. 2003;17:1941–1951
  50. Richters J, Knox S, Crawford J. Condom use and ‘withdrawal’: exploring gay men's practice of anal intercourse. International Journal of STD & AIDS. 2000;11(2):96–104
  51. Oral sex. Aidsmap. 21 December 2005. At: < http://www.aidsmap.com/en/docs/C858FF44-5E81-4F59-8030-B5A3C7A93654.asp>
  52. del Romero J, Marincovich B, Castilla J, et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS. 2002;16(9):1269–1297
  53. Fellatio. Aidsmap. 13 July 2004. At: < http://www.aidsmap.com/en/docs/D2C102B1-1CE1-4243-93E1-BA0DFEF60440.asp>
  54. Moench TR, Chipato T, Padian NS. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS. 2001;5:1595–1602
  55. Minnis AM, Padian NS. Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions. Sexually Transmitted Infections. 2005;8:193–200
  56. University of California, San Francisco. Clinical Trial: Effectiveness of the Diaphragm for HIV Prevention. At: < www.clinicaltrials.gov/ct/show/NCT00121459>
  57. Halperin DT. Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks, Part I. Review. AIDS Patient Care and STDS. 1999;13(12):717–730
  58. Karim SS, Ramjee G. Anal sex and HIV transmission in women. American Journal of Public Health. 1998;88(8):1265–1266
  59. American Foundation for AIDS Research. HIV prevention for men who have sex with men. Issue Brief. June 2006. At: < www.amfar.org/cgi-bin/iowa/programs/publicp/record.html?record=37>
  60. Training manual for men who have sex with men. New Delhi: NAZ Foundation India Trust; 2001;
  61. Philpott A, Knerr W, Boydell V. Pleasure and prevention: when good sex is safer sex. Reproductive Health Matters. 2006;14(28):23–31
  62. Levin RJ. Wet and dry sex – the impact of cultural influence in modifying vaginal function. Sexual and Relationship Therapy. 2005;20(4):
  63. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet. 2007;369:643–656
  64. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial. Lancet. 2005;369:657–666
  65. Auvert B, Talijaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298
  66. Rakai Health Sciences Program. Study presents new information on male circumcision to prevent spread of HIV in Africa. Press release 6 March 2007.
  67. New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications. WHO/UNAIDS Technical Consultation Male Circumcision and HIV Prevention: Research Implications for Policy and Programming. Montreux, 6–8 March 2007. Conclusions and Recommendations. At: < http://www.who.int/hiv/mediacentre/MCrecommendations_en.pdf>. Accessed 27 April 2007
  68. UNAIDS, WHO, UNFPA. Position Statement on Condoms and HIV Prevention. Geneva: WHO; July 2004;At: < http://data.unaids.org/una-docs/condom-policy_jul04_en.pdf>
  69. Cleland J, Ali MM, Shah I. Trends in behaviour among single vs. married young women in sub-Saharan Africa: the big picture. Reproductive Health Matters. 2006;14(28):7–22
  70. Carter M. Condoms reduce women's risk of contracting genital HPV, proves US study. Aidsmap News. 22 June 2006. At: < www.aidsmap.com/en/news>
  71. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Systematic Review. 2004;2:CD003255
  72. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Review. Bulletin of World Health Organization. 2004;82(6):454–461
  73. Steiner MJ, Cates W. Condoms and sexually-transmitted infections. New England Journal of Medicine. 2006;354:2642–2643
  74. American Foundation for AIDS Research. The effectiveness of condoms in preventing HIV transmission. Issue Brief No.1. January 2005. At: < www.amfar.org/binary-data/AMFAR_PUBLICATION/download_file/34.pdf>
  75. World Health Organization Department of Reproductive Health and Research. The Female Condom FC2. Joint WHO/UNAIDS/UNFPA Statement. 2005;
  76. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. New England Journal of Medicine. 2006;354:2645–2654
  77. Gerberding JL. Report to Congress. Prevention of Genital Human Papillomavirus Infection. Atlanta: US Centers for Disease Control and Prevention; January 2004;
  78. The Pleasure Project. Global Mapping of Pleasure-Focused Projects. 2005. At: < www.thepleasure-project.org>
  79. The FC2 female condom. At: < www.femalehealth.com>
  80. Coffey PS, Kilbourne-Brook M, Austin G, et al. Short-term acceptability of the PATH Woman's Condom among couples at three sites. Contraception. 2006;73:588–593
  81. Female condom use by men. Positively Aware. 1998;9(5):23
  82. Richters J, Gerofi J, Donovan B. Why do condoms break or slip off in use? An exploratory study. International Journal of STD & AIDS. 1995;6:11–18
  83. Heard I, Potard V, Costagliola D, et al. Contraceptive use in HIV positive women. Journal of Acquired Immune Deficiency Syndrome. 2004;36(2):714–720
  84. Panozzo L, Battegay M, Friedl A, et al. High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner – two challenging issues. Swiss Medical Weekly. 2003;133(7–8):124–127
  85. Buchacz K, van der Straten A, Saul J, et al. Sociodemographic, behavioral, and clinical correlates of inconsistent condom use in HIV-serodiscordant heterosexual couples. Journal of Acquired Immune Deficiency Syndrome. 2001;28(3):289–297
  86. Humphrey JH, Hargrove JW, Malaba LC, et al. ZVITAMBO Study Group HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS. 2006;20(10):1437–1446
  87. Van de Perre P, Simonson A, Msellati P, et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. New England Journal of Medicine. 1991;325(9):593–644
  88. Bouhnik AD, Preau M, Schiltz MA. Unprotected sex in regular partnerships among homosexual men living with HIV: a comparison between sero-nonconcordant and seroconcordant couples (ANRS-EN12-VESPA Study). AIDS. 2007;21(Suppl.1):S43–S48
  89. World Health Organization. Chronic HIV care with ARV therapy, integrated management of adolescent and adult illness, interim guidelines for first-level facility health workers. Geneva: WHO; January 2004;
  90. Smith DM, Richman DD, Little SJ. HIV superinfection. Journal of Infectious Diseases. 2005;192:438–444
  91. Cheonis N. Dual HIV infection. TheBody.com Winter 2005–06. At: < www.thebody.com/sfaf/winter06/dual.html>. Accessed 7 March 2007
  92. Overbaugh J. HIV transmission and pathogenesis: a viral perspective. Presentation Monday Plenary 01. International AIDS Conference. Toronto, 14 August 2006. At: < www.aids2006.org/Web/MOPL01.ppt>
  93. Gottlieb GS, Nickle DC, Jensen MA, et al. Dual HIV-1 infection associated with rapid disease progression. Lancet. 2004;363(9409):619–622
  94. Kalichman SC, Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sexually Transmitted Infections. 2003;79:59–61
  95. Wilson TE, Minkoff H. Condom use consistency associated with beliefs regarding HIV disease transmission among women receiving HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome. 2001;27:289–291
  96. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behaviour: a meta-analytic review. JAMA. 2004;292(2):224–236
  97. Diamond C, Richardson JL, Milam J, et al. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behaviour in HIV clinic patients. Journal of Acquired Immune Deficiency Syndrome. 2005;39(2):211–218
  98. Stephenson JM, Imrie J, Davis MM, et al. Is use of antiretroviral therapy among homosexual men associated with increased risk of transmission of HIV infection?. Sexually Transmitted Infections. 2003;79(1):7–10
  99. Bunnell R, Ekwaru JP, Solberg P, et al. Changes in sexual behaviour and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS. 2006;20:85–92
  100. Hayes RJ, Schulz KF, Plummer FA. The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. Journal of Tropical Medicine & Hygiene. 1995;98(1):1–8
  101. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: WHO; 2001;
  102. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections. 1999;75(1):3–17
  103. Rojanapithayakorn W. The 100% Condom Use Programme in Asia. Reproductive Health Matters. 2006;14(28):41–52
  104. Celentano DD, Nelson KE, Lyles CM, et al. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention programme. AIDS. 1998;12(5):F29–F36
  105. Leng HB, Wantha SS, Saidel T. Success of Cambodian HIV prevention efforts confirmed by low prevalence of sexually transmitted infections and declining HIV and risk behaviours. In: Proceedings of the Abstracts of XIV International Conference on AIDS, Barcelona, Spain, 6–10 July 2002.
  106. Meda N, Ndoye I, M'Boup S, et al. Low and stable HIV infection rates in Senegal: natural course of the epidemic or evidence for success of prevention?. AIDS. 1999;13:1397–1405
  107. Moses S, Ngugi EN, Costigan A, et al. Declining sexually transmitted disease and HIV prevalences among antenatal and family planning clinic attenders in Nairobi, Kenya, from 1992–1999. Abstract ThOrC727. XIII International Conference on AIDS, Durban, 9–15 July 2000.
  108. HPTN 039: A Phase III, randomized, double-blind, placebo-controlled trial of acyclovir for the reduction of HIV acquisition among high risk HSV-2 seropositive, HIV-seronegative individuals. At: < www.hptn.org/research_studies/hptn039.asp>. Accessed 7 July 2006
  109. Brunham RC, Plummer FA. A general model of sexually transmitted disease epidemiology and its implications for control. Medical Clinics of North America. 1990;74(6):1339–1352
  110. Over M, Piot P. HIV infection and sexually transmitted diseases. In: Disease Control Priorities in Developing Countries. New York: Oxford University Press; 1993;
  111. Steen R, Dallabetta G. The use of epidemiologic mass treatment and syndrome management for sexually transmitted disease control. Sexually Transmitted Diseases. 1999;26(4 Supp.1):S12–S22
  112. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet. 1994;344:246–248
  113. Ghys PD, Diallo MO, Ettiegne-Traore V, et al. Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers. AIDS. 2001;15(11):1421–1431
  114. Alary M, Mukenge-Tshibaka L, Bernier F, et al. Decline in the prevalence of HIV and sexually transmitted diseases among female sex workers in Cotonou, Benin, 1993–1999. AIDS. 2002;16(3):463–470
  115. Steen R, Vuylsteke B, DeCoito T, et al. Evidence of declining STD prevalence in a South African mining community following core-group intervention. Sexually Transmitted Diseases. 2000;27(1):1–8
  116. Levine WC, Revollo R, Kaune V, et al. Decline in sexually transmitted disease prevalence in female Bolivian sex workers: impact of an HIV prevention project. AIDS. 1998;12(14):1899–1906
  117. Wi T, Ramos E, Steen R, et al. STI declines among sex workers and clients following outreach, one-time presumptive treatment and regular screening of sex workers in the Philippines. Sexually Transmitted Infections. 2006;82(5):386–391
  118. Jana S, Bandyopadhyay N, Saha A, et al. Creating an enabling environment: lessons learnt from the Sonagachi Project, India. Research for Sex Work 2. 1999;At: < hcc.med.vu.nl/artikelen/jana.htm>. Accessed 23 March 2007
  119. Williams JR, Foss AM, Vickerman P, et al. What is the achievable effectiveness of the India AIDS Initiative intervention among female sex workers under target coverage? Model projections from southern India. Sexually Transmitted Infections. 2006;82:372–380
  120. Steen R, Mogasale V, Wi T, et al. Pursuing scale and quality in STI interventions with sex workers: initial results from Avahan India AIDS Initiative. Journal of Sexually Transmitted Infections. 2006;82(5):381–385
  121. Steen R, Ralepeli S, DeCoito T. Lesedi: services for women at high risk help reduce sexually transmitted infection (STI) prevalence in a South African mining community. FHI/UNAIDS Best Practices in HIV/AIDS Prevention Collection. Case Study Four. 2007;At: < www.fhi.org/en/HIVAIDS/pub/guide/bestpractices.htm>. Accessed 20 March 2007
  122. Aral S. Heterosexual TRansmission of HIV: the role of other sexually transmitted infections and behavior in its epidemiology prevention and control. Annual Review of Public Health. 1993;14:451–467
  123. Cohen MS. HIV and sexually transmitted diseases: lethal synergy. Topics in HIV Medicine. 2004;12:104–107
  124. WHO, UNFPA. Sexual and Reproductive Health of Women with HIV. Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. Geneva: WHO; 2006;
  125. WHO Guidelines for the Management of Sexually Transmitted Infections. Revised edition. Geneva: WHO; 2003;At: < www.who.int/reproductive-health/publications/rhr_01_10_mngt_stis/index.html>
  126. Mabey D, Peeling RW, Ustianowski A, et al. Diagnostics for the developing world. Nature Reviews Microbiology. 2004;2(3):231–240
  127. Pilcher CD, Price MA, Hoffman IF, et al. Frequent detection of acute primary HIV infection in men in Malawi. AIDS. 2004;18:517–524
  128. World Health OrganizationInternational Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Vol.10: Cervix Cancer Screening. Lyon: IARC Press; 2005;
  129. Kreuter A, Reimann G, Esser S, et al. [Screening and therapy of anal intraepithelial neoplasia (AIN) and anal carcinoma in patients with HIV-infection]. Deutsche Medizinische Wochenschrift 2003;128:38,1957–62.
  130. Bleeker MS, Hogewoning CJ, Voorhorst FJ, et al. Condom use promotes regression of human papillavirus-associated penile lesions in male sex partners of women with cervical intraepithelial neoplasia. International Journal of Cancer. 2003;107(5):804–810
  131. Hogewoning CJ, Bleeker MS, Vanden Brule AJ, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomised clinical trial. International Journal of Cancer. 2003;107(5):811–816
  132. Lowndes CM, Gill ON. Cervical cancer, human papillomavirus, and vaccination. BMJ. 2005;331(7522):915–916
  133. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004;364(9447):1757–1765
  134. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. New England Journal of Medicine. 2002;347(21):1645–1651
  135. Carter M. HIV-positive women often infected with multiple high-risk HPV strains not covered by vaccine. Aidsmap News. 27 July 2006;At: < www.aidsmap.com/en/news/A8AD650BD88D-42CC-AE47-DE40BBC6E48F.asp>
  136. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. Journal of American Medical Association. 2000;283(8):1031–1037
  137. Sun XW, Ellerbrock TV, Lungu O, et al. Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstetrics & Gynaecology. 1995;85:680–686
  138. Wright TJ, Subbarao S, Ellerbrock TV, et al. Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. American Journal of Obstetrics & Gynecology. 2001;184(3):279–285
  139. Melnikow J, Nuovo J, Willan AR, et al. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstetrics & Gynecology. 1998;92(4 Part 2):727–735
  140. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. International Journal of Gynaecological Pathology. 1993;12(2):186–192
  141. Lomalisa P, Smith T, Guidozzi F. Human immunodeficiency virus infection and invasive cervical cancer in South Africa. Gynecologic Oncology. 2000;77(3):460–463
  142. Chirenje ZM. HIV and cancer of the cervix. Best Practice & Research. Review. Clinical Obstetrics & Gynaecology. 2005;19(2):269–276
  143. Bower M, Mazhar D, Stebbing J. Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer?. Journal of Clinical Oncology. 2006;24(16):2417–2419
  144. van der Snoek EM, van der Ende ME, Schouten WR, et al. [Anorectal malignancies and dysplasia in HIV-positive men who have sex with men]. Nederlands Tijdschrift voor Geneeskunde. 2005;149(36):1989–1993
  145. WHO. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. Geneva: WHO; 2006;
  146. Heard I, Palefsky JM, Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antiviral Therapy. 2004;9(1):13–22
  147. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. Journal of National Cancer Institute. 2000;92:1823–1830
  148. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Journal of National Cancer Institute. 2000;92:1500–1510
  149. Engels EA, Goedert JJ. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future. Journal of National Cancer Institute. 2005;97(6):407–409
  150. Heard I, Tassie JM, Kazatchkine MD, et al. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS. 2002;16(13):1799–1802
  151. Minkoff H, Ahdieh L, Massad LS, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS. 2001;15(16):2157–2164
  152. Heard I, Tassie JM, Schmitz V, et al. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load (1). Obstetrics & Gynaecology. 2000;96(3):403–409
  153. Kreiss JK, Kiviat NB, Plummer FA, et al. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes. Sexually Transmitted Diseases. 1992;19(1):54–59
  154. Piketty C, Kazatchkine MD. Human papillomavirus-related cervical and anal disease in HIV-infected individuals in the era of highly active antiretroviral therapy. Current HIV/AIDS Reports. 2005;3:140–145
  155. Shapiro K, West K, Heise L. Standard of care in international phase III microbicide efficacy trials. Draft report for Global Campaign for Microbicides. March 2007;(Unpublished)
  156. Hawkes S, Collumbien M. The sexual health of men in India and Bangladesh; what are men's concerns? Programming for male involvement in reproductive health. Report of the meeting of WHO Regional Advisers in Reproductive Health. Washington DC: PAHO; September 2001;At: < whqlibdoc.who.int/hq/2002/WHO_FCH_RHR_02.3.pdf>
  157. Trotta MP, Ammassari A, Cozzi-Lepri A, et al. Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens. AIDS. 2003;17:1099–1102
  158. Miguez-Burbano MJ, Espinoza L, Lewis JE. HIV treatment adherence and sexual functioning. AIDS and Behaviour. 2007 Feb 13;[E-pub ahead of print]
  159. Richardson D, Lamba H, Goldmeier D, et al. Factors associated with sexual dysfunction in men with HIV infection. International Journal of STD & AIDS. 2006;17(11):764–767
  160. Bell C, Richardson D, Wall M, et al. HIV-associated female sexual dysfunction: clinical experience and literature review. International Journal of STD & AIDS. 2006;17(10):706–709
  161. Collumbien M, Hawkes S. Missing men's messages: does the reproductive health approach respond to men's sexual health needs?. Culture, Health and Sexuality. 2000;2:135–150
  162. AVSC InternationalInternational Planned Parenthood Federation Western Hemisphere Region. Literature review for the symposium on male participation in sexual and reproductive health: new paradigms. New York: IPPF WHR; 1999;
  163. Szasz I. Masculine identity and the meanings of sexuality: a review of research in Mexico. Reproductive Health Matters. 1998;6(12):97–104
  164. Weiss E, Rao Gupta G. Bridging the Gap: Addressing Gender and Sexuality in HIV Prevention. Washington DC: International Centre for Research on Women; 1998;
  165. Action Research in Community Health and Development. Perceptions of male members about reproductive health matters: preliminary evidence from a tribal area of Gujarat. In: Men as Supportive Partners in Reproductive Health. Moving from Rhetoric to Reality. New York: Population Council; 2000;
  166. Ray S, Gumbo N, Mbizvo M. Local voices: what some Harare men say about preparation for sex. Reproductive Health Matters. 1996;4(7):34–45
  167. Robey B, Drennan M. Male participation in reproductive health. Network. 1998;18(3):11–15
  168. Amirkhanian YA, Kelly JA, Kabakchieva E, et al. A randomized social network HIV prevention trial with young men who have sex with men in Russia and Bulgaria. AIDS. 2005;19(16):1897–1905
  169. Prevention and control of sexually transmitted infections: draft global strategy. World Health Organization, 59th World Health Assembly, Provisional agenda item 11.6. 18 May 2006;At: < www.who.int/gb/ebwha/pdf_files/WHA59/A59_11-en.pdf>
  170. Leading advocates express support for microbicide research, despite disappointing clinical trial results. Global Campaign for Microbicides/African Microbicides Advocacy Group/AIDS Vaccine Advocacy Coalition Joint Statement. 31 January 2007;At: < www.global-campaign.org/clientfiles/civil_soc_press_release%209.doc>
  171. TAC comment on the termination of Ushercell microbicide trial. Treatment Action Campaign Electronic Newsletter. 7 February 2007;At: < www.tac.org.za/nl20070207.html>
  172. HIV positive women and microbicides. Global Campaign for Microbicides. April 2006;At: < www.global-campaign.org/clientfiles/FS7-PositiveWomen-March07.pdf>

PII: S0968-8080(07)29034-2

doi: 10.1016/S0968-8080(07)29034-2

Reproductive Health Matters
Volume 15, Issue 29, Supplement , Pages 67-92 , May 2007

Article Tools

* Image Usage & Resolution